Area of research
Parasitology · Pathology and Forensic Medicine
Research interest
Research focused on Lung cancer and Crizotinib, with related work in Stage (stratigraphy), Computational biology, China. Notable publications include 'Prediction of protein structural class for low-similarity sequences using Chou’s pseudo amino acid composition and wavelet denoising', 'Prediction of subcellular location of apoptosis proteins by incorporating PsePSSM and DCCA coefficient based on LFDA dimensionality reduction', and 'China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)'.
Enhanced understanding of cinnamaldehyde’s therapeutic potential in osteoarthritis through bioinformatics and mechanistic validation of its anti-apoptotic effect
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study
Clinical features and outcomes of<i>ALK</i>rearranged non‐small cell lung cancer with primary resistance to crizotinib
Prediction of subcellular location of apoptosis proteins by incorporating PsePSSM and DCCA coefficient based on LFDA dimensionality reduction
Prediction of protein structural class for low-similarity sequences using Chou’s pseudo amino acid composition and wavelet denoising
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)
[China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)].
Extracting a few functionally reproducible biomarkers to build robust subnetwork-based classifiers for the diagnosis of cancer